Application of botulinum toxin to reduce the saliva in patients with amyotrophic lateral sclerosis

Aim: To demonstrate the effect of local application of Botox® in patients with amyotrophic lateral sclerosis (ALS), following our 2002 institutional protocol of sialorrhea treatment. Study Design: Clinical prospective. Material and Method: Five patients with ALS assisted at Clinic of Otolaryngology...

Descripción completa

Detalles Bibliográficos
Autor principal: Manrique, Dayse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441962/
https://www.ncbi.nlm.nih.gov/pubmed/16612515
http://dx.doi.org/10.1016/S1808-8694(15)31258-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441962/
https://www.ncbi.nlm.nih.gov/pubmed/16612515
http://dx.doi.org/10.1016/S1808-8694(15)31258-1

Ejemplares similares